Composition comprising in vitro expanded T-lymphocytes and vessel formation inhibitors suitable in the treatment of cancer

Details for Australian Patent Application No. 2009270434 (hide)

Owner SentoClone AB

Inventors Winqvist, Ola; Thorn, Magnus

Agent FB Rice

Pub. Number AU-A-2009270434

PCT Pub. Number WO2010/006808

Priority PA 2008 01025 18.07.08 DK; 61/081,804 18.07.08 US

Filing date 17 July 2009

Wipo publication date 21 January 2010

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2010/006808 Priority application(s): WO2010/006808

17 February 2011 Alteration of Name

  The name of the applicant has been altered to SentoClone International AB

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009270435-Medical use of the radical scavenger and antioxidant alpha-1-microglobulin

2009270415-Articles of manufacture releasing an active ingredient